Thymosin alpha 1 - Reimagine its broader applications in the immuno-oncology era.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Thymosin alpha 1 - Reimagine its broader applications in the immuno-oncology era.
- Published In:
- International immunopharmacology, 117, 109952 (2023)
- Authors:
- Mao, Li
- Database ID:
- RPEP-07159
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-07159APA
Mao, Li. (2023). Thymosin alpha 1 - Reimagine its broader applications in the immuno-oncology era.. International immunopharmacology, 117, 109952. https://doi.org/10.1016/j.intimp.2023.109952
MLA
Mao, Li. "Thymosin alpha 1 - Reimagine its broader applications in the immuno-oncology era.." International immunopharmacology, 2023. https://doi.org/10.1016/j.intimp.2023.109952
RethinkPeptides
RethinkPeptides Research Database. "Thymosin alpha 1 - Reimagine its broader applications in the..." RPEP-07159. Retrieved from https://rethinkpeptides.com/research/mao-2023-thymosin-alpha-1-reimagine
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.